Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine

Clinical Pharmacokinetics

Volumn 41, Issue SUPPL. 1, 2002, Pages 21-28

  Affrime, M ^a   Banfield, C ^a   Gupta, S ^a   Cohen, A ^b   Boutros, T ^a   Thonoor, M ^a   Cayen, M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Peninsular Testing Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYDESLORATADINE; DESLORATADINE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENDER; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RACE;

EID: 0036071053     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200241001-00004     Document Type: Article

References (10)

1. Gender differences in pharmacokinetics and pharmacodynamics
2. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs
3. Gender differences in pharmacokinetics
4. Gender effects in pharmacokinetics and pharmacodynamics
5. Influence of race or ethnicity on pharmacokinetics of drugs
6. Ethnic differences in drug disposition and responsiveness
7. 1-receptor antagonist, in patients with seasonal allergic rhinitis. Assessment during the spring and fall allergy seasons
8. Oral bioavailability of desloratadine is unaffected by food
9. A pharmacokinetic profile of desloratadine in healthy adults, including elderly
10. Lack of electrocardiographic effects of multiple high doses of desloratadine